Showing results (471-480 of 621) with videos related to
Sort By:
Pageof 63
Blood Purification|September 16, 1998
New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas aeruginosa contaminated dialysateB L Jaber, J A Gonski, M Cendoroglo, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
Soluble murine IL-1 receptor type I induces release of constitutive IL-1 alphaM G Netea, B J Kullberg, O C Boerman, et al.American Journal of Physiology. Renal Physiology|October 28, 2004
TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signalingR Misseri, D R Meldrum, C A Dinarello, et al.The Journal of Molecular and Cellular Immunology : JMCI|January 1, 1985
Human and murine interleukin 1 possess sequence and structural similaritiesP E Auron, L J Rosenwasser, K Matsushima, et al.Critical Care Medicine|August 14, 1999
Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial functionB S Cain, D R Meldrum, C A Dinarello, et al.Circulation|April 27, 1999
Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary eventsL M Biasucci, G Liuzzo, G Fantuzzi, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1988
IL-2 receptor(p55)/Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factorY Tagaya, M Okada, K Sugie, et al.Clinical Nephrology|December 1, 1996
Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole bloodB J Pereira, S Sundaram, T W Barrett, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1985
The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1J M Williams, D Deloria, J A Hansen, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Induction of circulating IL-1 receptor antagonist by IFN treatmentH Tilg, J W Mier, W Vogel, et al.Pageof 63